Command Palette

Search for a command to run...

Clinical Trials · NCT01410799

Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly

TerminatedPhase 2Sermorelin (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
University of Pennsylvania
Enrollment
13
Start date
May 2011
Locations
1 site, United States
Primary endpoint
Muscle Strength
View Sermorelin compound reference